The prevalence of PVT in cirrhosis has been reported to be 0.6% to 16%, and more commonly reported in patients awaiting liver transplantation. PVT is seen in up to 35% of cirrhotic patients with hepatocellular carcinoma. The lifetime risk of PVT in the general population is reported to be 1%.